Patents in the pharmaceutical sector are exclusive rights granting inventors a temporary monopoly, typically 20 years, on a novel drug compound. This legal shield protects significant R&D investments, enabling companies to recoup costs via high prices. Ultimately, this system fuels future medical breakthroughs, benefiting patients through new treatments while balancing innovation incentives against generic competition.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends